Pendal Group LTD Bio N Tech Se Transaction History

Pendal Group LTD

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2022 Jul 25, 2022	SELL	$123.25 - $186.24 $241 Million - $365 Million	-1,957,594 Closed	0 $0
Q1 2022 Apr 25, 2022	BUY	$126.25 - $231.85 $208,817 - $383,479	1,654 Added 0.08%	1,957,594 $334 Million
Q4 2021 Jan 18, 2022	BUY	$216.64 - $362.52 $108 Million - $181 Million	500,115 Added 34.35%	1,955,940 $504 Million
Q3 2021 Nov 05, 2021	BUY	$205.93 - $447.23 $300 Million - $651 Million	1,455,825 New	1,455,825 $397 Million

357

38.3M

2.45M

2.29M

Ticker BNTX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 242,684,992
Market Cap $27.4B
Description
BioNTech SE, a biotechnology company, develops and commercializes immunotherapies for cancer and other infectious diseases. The company is developing FixVac product candidates, including BNT111, which is in Phase II clinical trial for advance melanoma; BNT112 that is in Phase I/IIa clinical trial for prostate cancer; BNT113, which is in Phase II...

Get notified when there are updates to the investment portfolio of Pendal Group LTD, based on Form 13F filings with the SEC.

Stay updated on Pendal Group LTD with notifications on news.